Research programme: biodefence DNA vaccines - Ichor Medical Systems/USAMRIID

Drug Profile

Research programme: biodefence DNA vaccines - Ichor Medical Systems/USAMRIID

Alternative Names: Biodefense DNA vaccines - Ichor Medical Systems/USAMRIID; DNA vaccines - Ichor; Electroporation-mediated DNA vaccines - Ichor/US Army; EP-mediated DNA vaccines - Ichor; EP-mediated pDNA vaccines - Ichor; Plasmid DNA vaccines - Ichor

Latest Information Update: 02 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ichor Medical Systems; United States Army Medical Research Institute of Infectious Diseases
  • Class Bacterial vaccines; DNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Eastern equine encephalomyelitis; Venezuelan equine encephalomyelitis; Western equine encephalitis virus infections
  • Discontinued Anthrax

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Eastern equine encephalomyelitis (Prevention) in USA (IM, Injection)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Eastern equine encephalomyelitis (Prevention) in USA (Intradermal, Injection)
  • 30 Dec 2013 Discontinued - Preclinical for Anthrax in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top